Clinical experiences in fungal keratitis caused by Acremonium
Seong-Jae Kim,1,2 Yong-Wun Cho,1 Seong-Wook Seo,1,2 Sun-Joo Kim,2,3 Ji-Myong Yoo1,2
1Department of Ophthalmology, 2Gyeongsang Institute of Health Science, 3Department of Laboratory Medicine, Gyeongsang National University, College of Medicine, Jinju, Korea
Purpose: To report the predisposing risk factors, clinical presentation, management, and therapeutic outcomes of fungal keratitis caused by Acremonium.
Methods: This is a retrospective study of cases with Acremonium fungal keratitis that presented to our tertiary referral center between January 2006 and August 2012. Patient demographic and clinical details were determined and reported.
Results: Five cases of fungal keratitis from Acremonium species were identified in five patients (three males, two females). The mean age of the patients was of 73.4±5.46 years, with a mean follow-up time of 124±72 days. All patients had a history of corneal trauma with vegetable matter. Four cases were unresponsive to initial treatment (0.2% fluconazole, 0.15% amphotericin B) and required topical 5% natamycin, and, in two out of five cases, topical 1% voriconazole.
Conclusion: The most common risk factors for Acremonium fungal keratitis was ocular trauma. When a corneal lesion is found to be unresponsive to the initial treatment, we should consider adding or substituting topical natamycin or voriconazole for treatment.
Keywords: Acremonium, fungal keratitis, natamycin, prognosis, voriconazole
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]
Readers of this article also read:
Onishi SM, Asahi MG, Chou C, Gallemore RP
Published Date: 21 January 2015
Karli SZ, Liao SD, Carey AR, Lam BL, Wester ST
Published Date: 29 October 2014
Survey of Japanese ophthalmic surgeons regarding perioperative disinfection and antibiotic prophylaxis in cataract surgery
Matsuura K, Mori T, Miyamoto T, Suto C, Saeki Y, Tanaka S, Kawamura H, Ohkubo S, Tanito M, Inoue Y
Published Date: 29 September 2014
Toso A, Cappello E, Morselli S
Published Date: 11 September 2014
Intraoperative endoscopic observation of sclerotomy site after cannula removal for 23-gauge vitrectomy
Hikichi T, Kitamei H, Kosaka S, Shioya S, Takami K
Published Date: 28 February 2014
Ophthalmic viscosurgical device backflow into cartridge during intraocular lens insertion using injectors
Matsuura K, Inoue Y
Published Date: 31 January 2014
Wang PX, Koh VT, Cheng JF
Published Date: 29 January 2014
Cupisti A, Gallieni M, Rizzo MA, Caria S, Meola M, Bolasco P
Published Date: 4 October 2013
Caperton CV, Berman B
Published Date: 8 April 2011